The industry is rapidly changing, which provides a unique set of challenges for those developing and manufacturing biosimilars and generic medicines. Gain true insight on winning development, manufacturing, clinical and commercialisation strategies for biosimilars and generics in the global market.
Navigate the challenges in the clinic, the manufacture and development of biosimilar and generic medicines as well as explore the commercial aspects of the industry. This is your best chance to find out where the industry growth opportunities lie and what role they can play in your portfolio.
Heads of:
HTA
Market Access
Health Economics
Outcomes Research
Health Policy
Epidemiology
Pricing & Reimbursement
Pharmacoeconomics
Clinical trials
Clinical research
Post marketing Surveillance
Medical Affairs
Pharmacoepidemiology
Hear how RWE is shaping up decision making in healthcare
Understand the latest trends impacting evidence requirements for new drugs
Integrate payer expectations early in product development & market access strategies
Develop successful and transparent observational studies that optimize the commercialization of your medicine
Gain big value from your big data: assess collection, interpretation and communication strategies
Hear about new initiatives to combat low success rates of product submissions
Review the enabling technologies in evidence generation
Plan successful patient registry or PRO programmes
Discuss how to generate, apply and present ‘real world’ evidence to maximise patient access
Network with pioneers, influencers and innovators and return to your company with new ideas and relationships​